ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 226 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $860,394 | +18.8% | 65,479 | +13.9% | 0.00% | 0.0% |
Q2 2023 | $724,046 | -43.8% | 57,464 | -41.8% | 0.00% | -50.0% |
Q1 2023 | $1,288,909 | -19.0% | 98,767 | +9.5% | 0.00% | 0.0% |
Q4 2022 | $1,590,669 | -99.9% | 90,174 | +8.2% | 0.00% | 0.0% |
Q2 2022 | $1,235,502,000 | -54.5% | 83,311 | -30.9% | 0.00% | -50.0% |
Q1 2022 | $2,714,133,000 | -4.3% | 120,521 | -21.6% | 0.00% | 0.0% |
Q4 2021 | $2,835,544,000 | -19.6% | 153,688 | -41.7% | 0.00% | -20.0% |
Q3 2021 | $3,526,110,000 | -7.2% | 263,733 | +28.5% | 0.01% | 0.0% |
Q2 2021 | $3,799,252,000 | -56.3% | 205,254 | -64.6% | 0.01% | -61.5% |
Q1 2021 | $8,694,075,000 | +169.7% | 579,026 | +159.4% | 0.01% | +116.7% |
Q4 2020 | $3,223,788,000 | +879.1% | 223,254 | +451.9% | 0.01% | – |
Q3 2020 | $329,255,000 | +74.1% | 40,449 | +44.8% | 0.00% | – |
Q2 2020 | $189,093,000 | -75.2% | 27,931 | -74.2% | 0.00% | -100.0% |
Q1 2020 | $763,263,000 | +21.3% | 108,418 | +69.1% | 0.00% | +100.0% |
Q4 2019 | $629,181,000 | +78.6% | 64,104 | +99.8% | 0.00% | 0.0% |
Q3 2019 | $352,348,000 | -2.2% | 32,090 | +3.6% | 0.00% | 0.0% |
Q2 2019 | $360,100,000 | +2.8% | 30,963 | -15.6% | 0.00% | 0.0% |
Q1 2019 | $350,147,000 | +1131.3% | 36,703 | +1144.2% | 0.00% | – |
Q4 2018 | $28,438,000 | -89.1% | 2,950 | -83.9% | 0.00% | – |
Q3 2018 | $260,462,000 | +2.0% | 18,278 | -14.1% | 0.00% | – |
Q2 2018 | $255,468,000 | -90.6% | 21,289 | -90.3% | 0.00% | -100.0% |
Q1 2018 | $2,713,888,000 | -30.4% | 219,748 | -18.1% | 0.01% | -16.7% |
Q4 2017 | $3,901,684,000 | +53.0% | 268,157 | +49.3% | 0.01% | 0.0% |
Q3 2017 | $2,550,200,000 | -1.7% | 179,667 | -11.3% | 0.01% | -25.0% |
Q2 2017 | $2,593,643,000 | -23.7% | 202,588 | -24.0% | 0.01% | -11.1% |
Q1 2017 | $3,401,382,000 | +455.7% | 266,568 | +355.6% | 0.01% | +200.0% |
Q4 2016 | $612,136,000 | +125.7% | 58,506 | +184.1% | 0.00% | +200.0% |
Q3 2016 | $271,236,000 | -77.6% | 20,595 | -78.4% | 0.00% | -80.0% |
Q2 2016 | $1,211,580,000 | +569.9% | 95,400 | +596.8% | 0.01% | +400.0% |
Q1 2016 | $180,871,000 | -71.2% | 13,692 | -66.4% | 0.00% | -50.0% |
Q4 2015 | $627,104,000 | +8457.6% | 40,774 | +6799.2% | 0.00% | – |
Q3 2015 | $7,328,000 | -97.4% | 591 | -97.1% | 0.00% | -100.0% |
Q2 2015 | $281,439,000 | +356.7% | 20,573 | +299.2% | 0.00% | – |
Q1 2015 | $61,630,000 | +38.7% | 5,153 | +48.1% | 0.00% | – |
Q4 2014 | $44,427,000 | -22.2% | 3,479 | -18.3% | 0.00% | – |
Q3 2014 | $57,129,000 | +463.2% | 4,257 | +573.6% | 0.00% | – |
Q2 2014 | $10,144,000 | -93.9% | 632 | -94.2% | 0.00% | – |
Q1 2014 | $166,583,000 | +310.0% | 10,945 | +316.5% | 0.00% | – |
Q4 2013 | $40,629,000 | -100.0% | 2,628 | -100.0% | 0.00% | -100.0% |
Q2 2013 | $687,330,000,000 | – | 7,000,000 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |